In patients with SLE, increased serum IL-10 levels are associated with increased disease activity and increased risk of anti-SS-A/Ro antibody positivity, and elevated serum IL-6 levels are associated with an increased risk of heart and lung involvement. The gene discussed is CALR; the disease is systemic lupus erythematosus.